Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing…
Trending
- New Era for Autoimmune T-Cell Engagers Takes Centre Stage This October
- Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
- Amplia and Lilly Partner on Lung Cancer Combination Trial
- FDA Grants Breakthrough Status to Lilly’s Pancreatic Cancer Drug
- Supernus and Indivior Announce Merger to Create CNS Drug Leader
- Curium to Acquire Lantheus in $8 Billion Radiopharma Deal
- Ratio Therapeutics Raises $70 Million to Advance Cancer Radiopharmaceuticals
- IMPACT Partners Pharmanovia to Expand Senaparib Across 66 Countries
- EU Approves Datroway for First-Line Triple-Negative Breast Cancer
- miRecule, EMS Unit Partner on RNA Delivery Technologies
Top Headlines
Amplia and Lilly Partner on Lung Cancer Combination Trial
Amplia Therapeutics has entered into a clinical trial collaboration with Eli Lilly and Company to evaluate a new…
FDA Grants Breakthrough Status to Lilly’s Pancreatic Cancer Drug
Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted…
Supernus and Indivior Announce Merger to Create CNS Drug Leader
Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to combine in a tax-free, all-stock merger of…
Curium to Acquire Lantheus in $8 Billion Radiopharma Deal
Curium and Lantheus have announced a definitive agreement to combine their businesses in a deal valued at up to…
Ratio Therapeutics Raises $70 Million to Advance Cancer Radiopharmaceuticals
Ratio Therapeutics has secured $70 million in Series C financing to accelerate the development of its…
Featured Event
Clinical Trials
Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with…
Boehringer Advances Phase III Cancer Precision Medicine Trials
Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the…
uniQure Reports Early Promise for Epilepsy Gene Therapy
uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with…
Massive Bio, Optellum Partner to Advance Lung Cancer Trial Access
Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical…
Phase 3 Success Boosts Prospects for Iza-Bren
SystImmune and Bristol Myers Squibb have reported positive Phase 3 results for izalontamab brengitecan (iza-bren), an investigational bispecific…
GSK Drug Bepirovirsen Shows Promise in Redefining Chronic Hepatitis B Treatment
British pharmaceutical company GSK has reported encouraging late-stage clinical trial results for bepirovirsen, an investigational therapy for chronic…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Bristol Myers Squibb Expands AI Supercomputer for Drug Discovery
Bristol Myers Squibb (BMS) is significantly expanding its artificial intelligence capabilities with the deployment…
Excalipoint and DP Technology Partner on AI Antibody Discovery Platform
Excalipoint Therapeutics and DP Technology have announced a strategic collaboration to develop a new artificial…
Drug Research
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
FDA Proposes New Steps to Streamline Biosimilar Drug Development
The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the…
Insilico, CMS Partner on AI Drug Discovery Programs
Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical…
Manufacturing
Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing…
Cellares and SonomaBio Partner on Automated Treg Cell Therapy Manufacturing
Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of…
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub
UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia,…
LGM Pharma Expands U.S. Manufacturing With $15M Investment
LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of…
Terumo BCT, Taiwan Bio Partner on Treg Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
